Company profile for BioCorRx

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BioCorRx® is a leading-edge healthcare solutions company focused on improving the lives of those struggling with alcohol and opioid addiction. Designed to treat alcoholism and certain opioid addictions, the BioCorRx® Recovery Program is used by a network of independently owned and operated treatment centers located throughout the United States. The program consists of BioCorRx’s proprietary cognitive behavioral therapy (C...
BioCorRx® is a leading-edge healthcare solutions company focused on improving the lives of those struggling with alcohol and opioid addiction. Designed to treat alcoholism and certain opioid addictions, the BioCorRx® Recovery Program is used by a network of independently owned and operated treatment centers located throughout the United States. The program consists of BioCorRx’s proprietary cognitive behavioral therapy (CBT) program and peer recovery support mobile application and may include the use of certain medications such as naltrexone in various forms in conjunction as determined by the treating physician.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2390 E. Orangewood Ave. Suite 575 Anaheim, CA 92806
Telephone
Telephone
714-462-4880
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/08/15/2930898/0/en/BioCorRx-Reports-Business-Update-for-the-Second-Quarter-of-2024.html

GLOBENEWSWIRE
15 Aug 2024

https://www.globenewswire.com/news-release/2024/04/03/2856946/0/en/BioCorRx-Pharmaceuticals-Inc-Awarded-New-Patent-for-Novel-Compound-to-Treat-Pain-Depression-and-Schizophrenia.html

GLOBENEWSWIRE
03 Apr 2024
BioCorRx Reports Business Update for 2023
BioCorRx Reports Business Update for 2023

02 Apr 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/04/02/2855969/0/en/BioCorRx-Reports-Business-Update-for-2023.html

GLOBENEWSWIRE
02 Apr 2024

https://www.globenewswire.com//news-release/2024/02/28/2837155/0/en/BioCorRx-Pharmaceuticals-Inc-Awarded-NIDA-Grant-of-Approximately-11-million-Over-Three-Years-for-Research-on-BICX104-a-Naltrexone-Implant-in-Combination-with-Bupropion-for-the-Trea.html

GLOBENEWSWIRE
28 Feb 2024

https://www.globenewswire.com//news-release/2024/02/08/2826159/0/en/BioCorRx-Pharmaceuticals-Inc-Appoints-Neuroscientist-Dr-Kate-DeVarney-to-the-Board-of-Directors.html

GLOBENEWSWIRE
08 Feb 2024

https://www.globenewswire.com//news-release/2024/01/09/2806288/0/en/BioCorRx-Appoints-Renowned-Investment-and-Capital-Markets-Executive-Louis-Lucido-as-President.html

GLOBENEWSWIRE
09 Jan 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty